TSHA - Taysha Gene Therapies, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$11.50
DETAILS
HIGH:
$13.00
LOW:
$11.00
MEDIAN:
$11.00
CONSENSUS:
$11.50
UPSIDE:
109.47%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 100.0% |
| EBIT Margin | -1114.6% |
| EBITDA Margin | -1102.9% |
| Operating Margin | -1130.6% |
| Pretax Margin | -1115.3% |
| Cont. Ops Margin | -1115.3% |
| Net Margin | -1115.3% |
| Bottom Line Margin | -1115.3% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 12.23 |
| Quick Ratio | 12.23 |
| Solvency Ratio | -1.119 |
| Cash Ratio | 12.04 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-16.13
Peers avg: 19.5
|
| PEG Ratio | 2.90 |
| Forward PEG | 2.90 |
| Price/Book | 7.12 |
| Price/Sales | 179.93 |
| Price/FCF | -18.74 |
| Price/Op Cash Flow | -18.89 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0529 |
| Debt/Equity | 0.0736 |
| Debt/Capital | 0.0685 |
| Long-Term Debt/Capital | 0.0685 |
| Financial Leverage | 1.39 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.05 |
| Operating Cash Flow Ratio | -3.506 |
| Operating Cash Flow/Sales | -952.5% |
| Free Cash Flow/Operating Cash Flow | 100.8% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -1710.90 |
| Interest Coverage | -1753.9365 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -5.12 |
| Capital Expenditure Coverage | -126.14 |
| Dividend + Capital Expenditure Coverage | -126.14 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.03 |
| EPS | -0.341 |
| Debt/Share | 0.0570 |
| Cash/Share | 1.00 |
| Book Value/Share | 0.77 |
| Tangible BV/Share | 0.77 |
| Equity/Share | 0.77 |
| Operating Cash Flow/Share | -0.291 |
| Capital Expenditure/Share | 0.002 |
| FCF/Share | -0.293 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.986 |
| Price/Fair Value | 7.12 |
| Debt/Market Cap | 0.0119 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -11.41 |